What is TB rapid diagnostic kit distribution in India?

It is a business of sourcing affordable, non-invasive TB test kits (tongue/nasal swabs) from Indian manufacturers and selling them directly to rural health centres, ASHA networks, and private clinics in underserved areas. The article notes India cut TB cases by 21% using early screening; this business ensures remote villages get testing access within 2 weeks of symptoms — critical because half of TB deaths occur in the first 2 weeks post-diagnosis.

How much does it cost to start this business in India?

₹15-20 lakh total. Breakdown: ₹8-10 lakh for initial kit inventory, ₹2 lakh for packaging and labelling, ₹1 lakh for GST/medical device registration, ₹2-3 lakh for warehouse/storage, ₹2 lakh working capital. You can reduce this to ₹12 lakh by starting with smaller inventory and dropshipping from manufacturers initially.

Is TB diagnostic kit distribution profitable in India?

Yes. Gross margin is 50-60% (kit costs ₹300-400, sells for ₹800-1,200). A distributor selling 25,000-40,000 kits monthly can earn ₹200-300 lakh annually. Government bulk tenders (NACO, state TB programmes) add ₹100-150 lakh more. The market is growing because India still has 300,000+ annual TB deaths despite availability of cure — urgent policy push means government and NGOs will buy in bulk.

What regulations apply to TB diagnostic kit distribution in India?

Medical Device Rules 2017: Rapid diagnostic kits are 'in-vitro diagnostic devices' requiring registration with state Drugs Controller. GST is 12% on medical devices. TB testing is authorized under National TB Elimination Programme (NTEP) — state TB officers can approve your kits for government purchase. You need GST registration and a valid medical device seller's license (obtainable in 4-6 weeks).

TB Testing Kit Distribution India 2026 Business Guide

AI SummaryTB rapid diagnostic kit distribution is a ₹500-800 crore annual opportunity in India addressing 300,000+ preventable TB deaths yearly. The timing is urgent in 2026: India has proven it can reduce TB cases by 21% through early screening (Tamil Nadu's TN-KET project), yet rural and tribal areas lack affordable testing infrastructure. Distributors sourcing kits from low-cost Indian manufacturers can sell at ₹800-1,200 per kit (cost ₹300-400) directly to village health centres, ASHA workers, and government TB programmes. Government tenders and NGO partnerships make this high-margin (50-60%), scalable, and impactful. Best pursued by healthcare entrepreneurs, medical supply traders, or social enterprise founders in central/eastern India where TB burden is highest.